Asia Pacific Microfluidics Market Size & Outlook, 2026-2033
Global Market
Related Markets
Asia Pacific microfluidics market highlights
- The Asia Pacific microfluidics market generated a revenue of USD 8,106.1 million in 2025.
- The market is expected to grow at a CAGR of 13.1% from 2026 to 2033.
- In terms of segment, microfluidic components was the largest revenue generating product in 2025.
- Microfluidic Components is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2026 to 2033.
Asia Pacific data book summary
| Market revenue in 2025 | USD 8,106.1 million |
| Market revenue in 2033 | USD 21,606.5 million |
| Growth rate | 13.1% (CAGR from 2026 to 2033) |
| Largest segment | Microfluidic components |
| Fastest growing segment | Microfluidic Components |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Microfluidic Components, Microfluidic-based Devices |
| Key market players worldwide | Illumina Inc, Roche Holding AG ADR, PerkinElmer, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Abbott Laboratories, Thermo Fisher Scientific Inc, Standard BioTools Inc |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 19.3% of the global microfluidics market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- MEA is the fastest growing regional market and is projected to reach USD 7,674.3 million by 2033.
Asia Pacific is the fastest growing market owing to sophisticated research infrastructure, developing economy, and affordable labor. International players are keen on investing in untapped APAC market. The market for diagnostic tests based on microfluidic is majorly dominated by foreign players, however, key players in the region are proposing innovative and interesting solutions in terms of performance, and more significantly in terms of price, which can allow them to boost their market share in the coming years.
The Government in China has set up a strategic plan to broadly enhance the local industry and make the country an important player. This plan, named Made in China 2025, incorporates a focus on medical devices and pharmaceuticals. As a vital tool for life sciences and diagnostics applications, microfluidic technology is expected to benefit the money spent in the perspective of this strategic plan.
No credit card required*
Publish Date: Jun 02, 2025
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Microfluidics Market Scope
Microfluidics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Agilent Technologies Inc | View profile | 17,700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | www.agilent.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Standard BioTools Inc | View profile | 539 | 2 Tower Place, Suite 2000, South San Francisco, CA, United States, 94080 | www.standardbio.com |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | www.perkinelmer.com |
Asia Pacific Microfluidics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Microfluidics Market Outlook will help companies and investors design strategic landscapes.
Microfluidic Components was the largest segment with a revenue share of 89.45% in 2025.
Horizon Databook has segmented the Asia Pacific microfluidics market based on microfluidic components, microfluidic-based devices covering the revenue growth of each sub-segment from 2021 to 2033.
Asia Pacific is the fastest growing market owing to sophisticated research infrastructure, developing economy, and affordable labor. International players are keen on investing in untapped APAC market. The market for diagnostic tests based on microfluidic is majorly dominated by foreign players, however, key players in the region are proposing innovative and interesting solutions in terms of performance, and more significantly in terms of price, which can allow them to boost their market share in the coming years.
The Government in China has set up a strategic plan to broadly enhance the local industry and make the country an important player. This plan, named Made in China 2025, incorporates a focus on medical devices and pharmaceuticals. As a vital tool for life sciences and diagnostics applications, microfluidic technology is expected to benefit the money spent in the perspective of this strategic plan.
- Asia Pacific Microfluidics Market Product Outlook (Revenue, USD Million , 2021-2033)
- Microfluidic Components
- Microfluidic-based Devices
- Asia Pacific Microfluidics Market Technology Outlook (Revenue, USD Million , 2021-2033)
- Lab-on-a-Chip
- Continuous Flow Microfluidics
- Electrophoresis and Microfluidics
- Acoustofluidics and Microfluidics
- Optofluidics and Microfluidics
- Organ-on-a-Chip
- Asia Pacific Microfluidics Market Material Type Outlook (Revenue, USD Million , 2021-2033)
- PDMS
- Glass
- Polymer
- Silicon
- Others
- Asia Pacific Microfluidics Market Application Outlook (Revenue, USD Million , 2021-2033)
- Medical
- Non-medical
Reasons to subscribe to Microfluidics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Microfluidics Market Outlook databook
- Our clientele includes a mix of Microfluidics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific Microfluidics Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific Microfluidics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Asia Pacific Microfluidics Market, 2021-2033 (US$M)
Asia Pacific microfluidics market statistics, by product, 2021-2033 (US$M)
